XNYS 05 May, 2026 10:45 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Christophe Pierre Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 323 | 879 (0%) | 0% | 0 | Common Stock | |
| Christophe Pierre Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 556 | 556 (0%) | 0% | 0 | Common Stock | |
| Cheryl B. Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 24 | 5,917 | - | - | Deferred Stock Units | |
| Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 24 | 6,663 (0%) | 0% | 0 | Common Stock | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.85 per share. | 01 Mar 2026 | 372 | 2,859 (0%) | 0% | 76.8 | 28,588 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 838 | 3,231 (0%) | 0% | 0 | Common Stock | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 838 | 1,676 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | 19 Feb 2026 | 6,851 | 20,205 (0%) | 0% | 75.8 | 519,032 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2026 | 34,898 | 204,790 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 3,960 | 0 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 4,362 | 4,363 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 2,797 | 8,391 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 1,806 | 213,907 (0%) | 0% | 74.7 | 134,962 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 3,960 | 215,713 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 1,990 | 211,753 (0%) | 0% | 74.7 | 148,713 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 4,362 | 213,743 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 33,104 | 209,381 (0%) | 0% | 74.7 | 2,473,862 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 2,797 | 242,485 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2026 | 34,898 | 239,688 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2026 | 132,190 | 1,551,003 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 16,265 | 0 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 16,524 | 16,524 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 8,832 | 26,498 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 7,865 | 1,576,860 (0%) | 0% | 74.7 | 587,751 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 16,265 | 1,584,725 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 7,990 | 1,568,460 (0%) | 0% | 74.7 | 597,093 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 16,524 | 1,576,450 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 132,099 | 1,559,926 (0%) | 0% | 74.7 | 9,871,758 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 8,832 | 1,692,025 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2026 | 132,190 | 1,683,193 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | EVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2026 | 14,804 | 64,013 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | EVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,839 | 0 | - | - | Restricted Stock Units | |
| Vance R. Brown | EVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,851 | 1,851 | - | - | Restricted Stock Units | |
| Vance R. Brown | EVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,118 | 3,357 | - | - | Restricted Stock Units | |
| Vance R. Brown | EVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 890 | 54,244 (0%) | 0% | 74.7 | 66,510 | Common Stock |
| Vance R. Brown | EVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,839 | 55,134 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | EVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 895 | 53,295 (0%) | 0% | 74.7 | 66,883 | Common Stock |
| Vance R. Brown | EVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,851 | 54,190 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | EVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 12,792 | 52,339 (0%) | 0% | 74.7 | 955,946 | Common Stock |
| Vance R. Brown | EVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,118 | 65,131 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | EVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2026 | 14,804 | 49,209 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 1,229 | 55,792 (0%) | 0% | 74.7 | 91,843 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2026 | 25,380 | 50,370 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2026 | 25,380 | 75,750 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 2,237 | 77,987 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 25,150 | 52,837 (0%) | 0% | 74.7 | 1,879,460 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 3,173 | 56,010 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 1,535 | 54,475 (0%) | 0% | 74.7 | 114,711 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 2,546 | 57,021 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 2,237 | 6,713 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 3,173 | 3,173 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 2,546 | 0 | - | - | Restricted Stock Units | |
| Jonathan R. Monson | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 990 | 0 | - | - | Restricted Stock Units | |
| Jonathan R. Monson | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,058 | 1,058 | - | - | Restricted Stock Units | |
| Jonathan R. Monson | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,766 | 5,300 | - | - | Restricted Stock Units | |
| Jonathan R. Monson | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 440 | 37,986 (0%) | 0% | 74.7 | 32,881 | Common Stock |
| Jonathan R. Monson | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,766 | 37,636 (0%) | 0% | 0 | Common Stock | |
| Jonathan R. Monson | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 990 | 38,426 (0%) | 0% | 0 | Common Stock | |
| Jonathan R. Monson | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 470 | 37,436 (0%) | 0% | 74.7 | 35,123 | Common Stock |
| Jonathan R. Monson | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,058 | 37,906 (0%) | 0% | 0 | Common Stock | |
| Jonathan R. Monson | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 788 | 36,848 (0%) | 0% | 74.7 | 58,887 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 661 | 661 | - | - | Restricted Stock Units | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 637 | 0 | - | - | Restricted Stock Units | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,413 | 4,239 | - | - | Restricted Stock Units | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 283 | 2,393 (0%) | 0% | 74.7 | 21,149 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 637 | 2,676 (0%) | 0% | 0 | Common Stock | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 296 | 2,039 (0%) | 0% | 74.7 | 22,120 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 661 | 2,335 (0%) | 0% | 0 | Common Stock | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 690 | 1,674 (0%) | 0% | 74.7 | 51,564 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,413 | 2,364 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 200 | 15,808 (0%) | 0% | 74.7 | 14,946 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 329 | 16,603 (0%) | 0% | 74.7 | 24,586 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 990 | 17,593 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 588 | 16,008 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 990 | 0 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,124 | 1,124 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 588 | 1,767 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 291 | 17,302 (0%) | 0% | 74.7 | 21,746 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,124 | 16,932 (0%) | 0% | 0 | Common Stock | |
| Padraig Andrew OConnor | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 500 | 1,502 | - | - | Restricted Stock Units | |
| Padraig Andrew OConnor | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 500 | 4,986 (0%) | 0% | 0 | Common Stock | |
| Padraig Andrew OConnor | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 199 | 4,787 (0%) | 0% | 74.7 | 14,871 | Common Stock |
| Padraig Andrew OConnor | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,190 | 5,977 (0%) | 0% | 0 | Common Stock | |
| Padraig Andrew OConnor | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 449 | 5,528 (0%) | 0% | 74.7 | 33,554 | Common Stock |
| Padraig Andrew OConnor | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 905 | 6,433 (0%) | 0% | 0 | Common Stock | |
| Padraig Andrew OConnor | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 339 | 6,094 (0%) | 0% | 74.7 | 25,333 | Common Stock |
| Padraig Andrew OConnor | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,190 | 1,190 | - | - | Restricted Stock Units | |
| Padraig Andrew OConnor | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 905 | 0 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 43,776 | 43,776 | - | - | Stock Option (Right to Buy) | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 3,462 | 171,504 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.12 per share. | 12 Feb 2026 | 1,612 | 169,892 (0%) | 0% | 74.1 | 119,481 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 3,462 | 6,924 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 18,550 | 18,550 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 13,704 | 1,425,439 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 131,329 | 131,329 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 55,652 | 55,652 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 13,704 | 27,408 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.12 per share. | 12 Feb 2026 | 6,626 | 1,418,813 (0%) | 0% | 74.1 | 491,119 | Common Stock |
| Vance R. Brown | EVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 17,510 | 17,510 | - | - | Stock Option (Right to Buy) | |
| Vance R. Brown | EVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 7,420 | 7,420 | - | - | Restricted Stock Units | |
| Vance R. Brown | EVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 1,442 | 2,886 | - | - | Restricted Stock Units | |
| Vance R. Brown | EVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.12 per share. | 12 Feb 2026 | 488 | 34,405 (0%) | 0% | 74.1 | 36,171 | Common Stock |
| Vance R. Brown | EVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 1,442 | 34,893 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 2,692 | 26,292 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 35,817 | 35,817 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.12 per share. | 12 Feb 2026 | 1,302 | 24,990 (0%) | 0% | 74.1 | 96,504 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 2,692 | 5,386 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 15,178 | 15,178 | - | - | Restricted Stock Units | |
| Jonathan R. Monson | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 11,805 | 11,805 | - | - | Restricted Stock Units | |
| Jonathan R. Monson | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 1,154 | 36,443 (0%) | 0% | 0 | Common Stock | |
| Jonathan R. Monson | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.12 per share. | 12 Feb 2026 | 573 | 35,870 (0%) | 0% | 74.1 | 42,471 | Common Stock |
| Jonathan R. Monson | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 1,154 | 2,308 | - | - | Restricted Stock Units | |
| Jonathan R. Monson | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 27,857 | 27,857 | - | - | Stock Option (Right to Buy) | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 481 | 1,193 (0%) | 0% | 0 | Common Stock | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 5,584 | 5,584 | - | - | Stock Option (Right to Buy) | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 6,071 | 6,071 | - | - | Restricted Stock Units | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 481 | 962 | - | - | Restricted Stock Units | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.12 per share. | 12 Feb 2026 | 242 | 951 (0%) | 0% | 74.1 | 17,937 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 11,143 | 11,143 | - | - | Stock Option (Right to Buy) | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 961 | 15,758 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.12 per share. | 12 Feb 2026 | 338 | 15,420 (0%) | 0% | 74.1 | 25,053 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 961 | 1,924 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 4,722 | 4,722 | - | - | Restricted Stock Units | |
| Padraig Andrew OConnor | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.12 per share. | 12 Feb 2026 | 457 | 4,486 (0%) | 0% | 74.1 | 33,873 | Common Stock |
| Padraig Andrew OConnor | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 1,058 | 2,116 | - | - | Restricted Stock Units | |
| Padraig Andrew OConnor | EVP, Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 5,059 | 5,059 | - | - | Restricted Stock Units | |
| Padraig Andrew OConnor | EVP, Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 11,939 | 11,939 | - | - | Stock Option (Right to Buy) | |
| Padraig Andrew OConnor | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 1,058 | 4,943 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 02 Feb 2026 | 49,407 | 1,526,289 (0%) | 0% | 24.6 | 1,212,942 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.09 per share. | 02 Feb 2026 | 46,347 | 1,572,636 (0%) | 0% | 27.1 | 1,255,540 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 94.06 per share. | 02 Feb 2026 | 1,200 | 1,571,436 (0%) | 0% | 94.1 | 112,868 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 93.49 per share. | 02 Feb 2026 | 159,701 | 1,411,735 (0%) | 0% | 93.5 | 14,930,526 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 46,347 | 231,739 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 49,407 | 98,814 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 3,177 | 0 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.09 per share. | 01 Dec 2025 | 6,952 | 30,552 (0%) | 0% | 27.1 | 188,330 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 01 Dec 2025 | 6,175 | 36,727 (0%) | 0% | 24.5 | 151,596 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.71 per share. | 01 Dec 2025 | 3,177 | 39,904 (0%) | 0% | 22.7 | 72,150 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 01 Dec 2025 | 1,009 | 40,913 (0%) | 0% | 17.3 | 17,415 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 101.55 per share. | 01 Dec 2025 | 17,313 | 23,600 (0%) | 0% | 101.6 | 1,758,189 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 6,952 | 0 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 1,009 | 0 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 6,175 | 0 | - | - | Stock Option (Right to Buy) | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Nov 2025 | 260 | 14,797 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 690 | 177,652 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 9,610 | 168,042 (0%) | 0% | 0 | Common Stock | |
| Ellen M. Zane | Director | Sale of securities on an exchange or to another person at price $ 98.28 per share. | 06 Nov 2025 | 12,891 | 24,134 (0%) | 0% | 98.3 | 1,266,978 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 03 Nov 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 100.75 per share. | 03 Nov 2025 | 3,600 | 224,742 (0%) | 0% | 100.7 | 362,693 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 99.76 per share. | 03 Nov 2025 | 16,928 | 207,814 (0%) | 0% | 99.8 | 1,688,749 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 99.14 per share. | 03 Nov 2025 | 29,472 | 178,342 (0%) | 0% | 99.1 | 2,921,895 | Common Stock |
| Ellen M. Zane | Director | Other type of transaction at price $ 0.00 per share. | 29 Oct 2025 | 12,891 | 37,025 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Oct 2025 | 149,992 | 213,679 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Oct 2025 | 73,996 | 363,671 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Oct 2025 | 88,197 | 289,675 (0%) | 0% | 0 | Common Stock | |
| Ellen M. Zane | Director | Sale of securities on an exchange or to another person at price $ 102.24 per share. | 27 Oct 2025 | 2,901 | 24,134 (0%) | 0% | 102.2 | 296,599 | Common Stock |
| Ellen M. Zane | Director | Sale of securities on an exchange or to another person at price $ 101.13 per share. | 27 Oct 2025 | 9,990 | 27,035 (0%) | 0% | 101.1 | 1,010,301 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 01 Oct 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 98.91 per share. | 01 Oct 2025 | 8,245 | 220,097 (0%) | 0% | 98.9 | 815,482 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 98.38 per share. | 01 Oct 2025 | 41,755 | 178,342 (0%) | 0% | 98.4 | 4,107,844 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 02 Sep 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 50,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 105.85 per share. | 02 Sep 2025 | 28,170 | 178,342 (0%) | 0% | 105.8 | 2,981,755 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 104.89 per share. | 02 Sep 2025 | 21,830 | 206,512 (0%) | 0% | 104.9 | 2,289,661 | Common Stock |
| Jonathan R. Monson | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.41 per share. | 02 Aug 2025 | 528 | 35,289 (0%) | 0% | 105.4 | 55,656 | Common Stock |
| Jonathan R. Monson | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2025 | 1,090 | 35,817 (0%) | 0% | 0 | Common Stock | |
| Jonathan R. Monson | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2025 | 1,090 | 0 | - | - | Restricted Stock Units | |
| Edward J. Ludwig | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Aug 2025 | 500 | 17,979 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 104.63 per share. | 01 Aug 2025 | 50,000 | 178,342 (0%) | 0% | 104.6 | 5,231,670 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 01 Aug 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 50,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.71 per share. | 01 Aug 2025 | 3,176 | 39,904 (0%) | 0% | 22.7 | 72,127 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.09 per share. | 01 Aug 2025 | 6,952 | 30,552 (0%) | 0% | 27.1 | 188,330 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 01 Aug 2025 | 6,176 | 36,728 (0%) | 0% | 24.6 | 151,621 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 3,176 | 3,177 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 6,176 | 6,175 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 1,009 | 1,009 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 6,952 | 6,952 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 104.63 per share. | 01 Aug 2025 | 17,313 | 23,600 (0%) | 0% | 104.6 | 1,811,520 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 01 Aug 2025 | 1,009 | 40,913 (0%) | 0% | 17.3 | 17,415 | Common Stock |
| Yoshiaki Fujimori | Director | Sale of securities on an exchange or to another person at price $ 106.99 per share. | 29 Jul 2025 | 2,901 | 2,081 (0%) | 0% | 107.0 | 310,378 | Common Stock |
| Edward J. Ludwig | Director | Sale of securities on an exchange or to another person at price $ 106.03 per share. | 25 Jul 2025 | 4,000 | 18,479 (0%) | 0% | 106.0 | 424,120 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 01 Jul 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 50,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 106.97 per share. | 01 Jul 2025 | 50,000 | 178,342 (0%) | 0% | 107.0 | 5,348,315 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.78 per share. | 01 Jul 2025 | 1,952 | 33,451 (0%) | 0% | 104.8 | 204,531 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 4,036 | 0 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 4,036 | 35,403 (0%) | 0% | 0 | Common Stock | |
| Jonathan R. Monson | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 22,173 | 22,173 | - | - | Stock Option (Right to Buy) | |
| Jonathan R. Monson | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 8,350 | 8,350 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 102.88 per share. | 04 Jun 2025 | 56,372 | 178,342 (0%) | 0% | 102.9 | 5,799,630 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 04 Jun 2025 | 56,372 | 234,714 (0%) | 0% | 26.2 | 1,474,128 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 56,372 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 103.39 per share. | 02 Jun 2025 | 89,921 | 1,476,882 (0%) | 0% | 103.4 | 9,296,950 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 56,212 | 0 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 49,407 | 148,221 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 02 Jun 2025 | 56,212 | 1,591,918 (0%) | 0% | 17.3 | 970,219 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 02 Jun 2025 | 49,407 | 1,641,325 (0%) | 0% | 24.6 | 1,212,942 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 104.05 per share. | 02 Jun 2025 | 74,522 | 1,566,803 (0%) | 0% | 104.1 | 7,754,186 | Common Stock |
| Edward J. Ludwig | Director | Sale of securities on an exchange or to another person at price $ 104.59 per share. | 29 May 2025 | 4,000 | 22,479 (0%) | 0% | 104.6 | 418,368 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 106.42 per share. | 21 May 2025 | 4,826 | 31,367 (0%) | 0% | 106.4 | 513,583 | Common Stock |
| David C. Habiger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 5,628 (0%) | 0% | 0 | Common Stock | |
| Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 26,479 (0%) | 0% | 0 | Common Stock | |
| David S. Wichmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 41,582 (0%) | 0% | 0 | Common Stock | |
| Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 37,025 (0%) | 0% | 0 | Common Stock | |
| Yoshiaki Fujimori | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 4,982 (0%) | 0% | 0 | Common Stock | |
| John E. Sununu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 54,723 (0%) | 0% | 0 | Common Stock | |
| Cheryl B. Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 5,288 | - | - | Deferred Stock Units | |
| Cheryl B. Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 605 | 5,893 | - | - | Deferred Stock Units | |
| Jessica L. Mega | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 8,235 (0%) | 0% | 0 | Common Stock | |
| Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 605 | 6,639 (0%) | 0% | 0 | Common Stock | |
| Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 6,034 (0%) | 0% | 0 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 02 May 2025 | 4,204 | 25,195 (0%) | 0% | 0 | Common Stock | ||
| John Bradley Sorenson | EVP, Global Operations | 02 May 2025 | 4,204 | 4,204 | - | - | Restricted Stock Units | ||
| John Bradley Sorenson | EVP, Global Operations | 02 May 2025 | 4,572 | 18,705 (0%) | 0% | 104.5 | 477,957 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 02 May 2025 | 1,918 | 23,277 (0%) | 0% | 104.9 | 201,256 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 2,102 | 24,337 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 2,102 | 2,102 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.93 per share. | 02 May 2025 | 1,017 | 23,320 (0%) | 0% | 104.9 | 106,714 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 102.13 per share. | 01 May 2025 | 91,282 | 1,535,706 (0%) | 0% | 102.1 | 9,322,266 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 102.92 per share. | 01 May 2025 | 73,161 | 1,626,988 (0%) | 0% | 102.9 | 7,529,708 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 01 May 2025 | 49,407 | 1,700,149 (0%) | 0% | 24.6 | 1,212,942 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 01 May 2025 | 56,212 | 1,650,742 (0%) | 0% | 17.3 | 970,219 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 49,407 | 197,628 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 56,212 | 56,212 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 01 May 2025 | 1,009 | 39,549 (0%) | 0% | 17.3 | 17,415 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.71 per share. | 01 May 2025 | 3,177 | 38,540 (0%) | 0% | 22.7 | 72,150 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 01 May 2025 | 6,176 | 35,363 (0%) | 0% | 24.6 | 151,621 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.09 per share. | 01 May 2025 | 6,952 | 29,187 (0%) | 0% | 27.1 | 188,330 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 3,177 | 6,353 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 6,176 | 12,351 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 1,009 | 2,018 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 6,952 | 13,904 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 102.06 per share. | 01 May 2025 | 17,314 | 22,235 (0%) | 0% | 102.1 | 1,766,982 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 95.09 per share. | 21 Apr 2025 | 4,826 | 36,193 (0%) | 0% | 95.1 | 458,904 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 49,407 | 247,035 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 56,211 | 112,424 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 01 Apr 2025 | 56,211 | 1,709,565 (0%) | 0% | 17.3 | 970,202 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 100.01 per share. | 01 Apr 2025 | 164,442 | 1,594,530 (0%) | 0% | 100.0 | 16,445,072 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 01 Apr 2025 | 49,407 | 1,758,972 (0%) | 0% | 24.6 | 1,212,942 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 100.85 per share. | 21 Mar 2025 | 4,826 | 41,019 (0%) | 0% | 100.8 | 486,702 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.50 per share. | 03 Mar 2025 | 5,949 | 8,063 (0%) | 0% | 37.5 | 223,088 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 5,949 | 2,383 | - | - | Stock Option (Right to Buy) | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Sale of securities on an exchange or to another person at price $ 104.63 per share. | 03 Mar 2025 | 482 | 432 (0%) | 0% | 104.6 | 50,432 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Sale of securities on an exchange or to another person at price $ 104.97 per share. | 03 Mar 2025 | 7,149 | 914 (0%) | 0% | 105.0 | 750,465 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.16 per share. | 28 Feb 2025 | 7,218 | 11,519 (0%) | 0% | 42.2 | 304,311 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 837 | 2,514 | - | - | Restricted Stock Units | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 7,218 | 0 | - | - | Stock Option (Right to Buy) | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.79 per share. | 28 Feb 2025 | 355 | 2,114 (0%) | 0% | 103.8 | 36,845 | Common Stock |
| Emily M. Woodworth | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 837 | 2,469 (0%) | 0% | 0 | Common Stock | |
| Emily M. Woodworth | SVP, Global Controller and CAO | Sale of securities on an exchange or to another person at price $ 101.13 per share. | 28 Feb 2025 | 9,887 | 1,632 (0%) | 0% | 101.1 | 999,872 | Common Stock |
| Ellen M. Zane | Director | Sale of securities on an exchange or to another person at price $ 104.23 per share. | 24 Feb 2025 | 13,586 | 34,944 (0%) | 0% | 104.2 | 1,416,134 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 24 Feb 2025 | 2,688 | 25,766 (0%) | 0% | 104 | 279,552 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 24 Feb 2025 | 4,675 | 28,454 (0%) | 0% | 104.3 | 487,369 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 340 | 5,234 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 340 | 178,342 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 1,700 | 178,682 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Sale of securities on an exchange or to another person at price $ 104.64 per share. | 21 Feb 2025 | 4,826 | 45,845 (0%) | 0% | 104.6 | 504,993 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Feb 2025 | 1,000 | 180,382 (0%) | 0% | 0 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 19 Feb 2025 | 1,510 | 33,129 (0%) | 0% | 105.4 | 159,079 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | Sale of securities on an exchange or to another person at price $ 104.67 per share. | 18 Feb 2025 | 14,630 | 232,618 (0%) | 0% | 104.7 | 1,531,366 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 18,533 | 37,067 | - | - | Stock Option (Right to Buy) | |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 16,865 | 0 | - | - | Stock Option (Right to Buy) | |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 9,483 | 37,934 | - | - | Stock Option (Right to Buy) | |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 15,642 | 31,285 | - | - | Stock Option (Right to Buy) | |
| Daniel J. Brennan | EVP and CFO | Sale of securities on an exchange or to another person at price $ 105.24 per share. | 18 Feb 2025 | 67,333 | 225,808 (0%) | 0% | 105.2 | 7,086,111 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.12 per share. | 18 Feb 2025 | 9,483 | 293,141 (0%) | 0% | 40.1 | 380,458 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.09 per share. | 18 Feb 2025 | 15,642 | 283,658 (0%) | 0% | 27.1 | 423,742 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 18 Feb 2025 | 16,865 | 268,016 (0%) | 0% | 17.3 | 291,090 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Sale of securities on an exchange or to another person at price $ 104.08 per share. | 18 Feb 2025 | 2,900 | 247,248 (0%) | 0% | 104.1 | 301,818 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 18 Feb 2025 | 18,533 | 251,151 (0%) | 0% | 24.5 | 454,985 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | 18 Feb 2025 | 3,303 | 20,991 (0%) | 0% | 105.2 | 347,443 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 18 Feb 2025 | 2,657 | 24,294 (0%) | 0% | 104.4 | 277,417 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,362 | 247,700 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 2,110 | 245,590 (0%) | 0% | 106.1 | 223,892 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,243 | 249,833 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 2,052 | 247,781 (0%) | 0% | 106.1 | 217,738 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,584 | 252,365 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 2,217 | 250,148 (0%) | 0% | 106.1 | 235,246 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 8,950 | 8,950 | - | - | Restricted Stock Units | |
| Daniel J. Brennan | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 23,031 | 23,031 | - | - | Stock Option (Right to Buy) | |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,362 | 8,725 | - | - | Restricted Stock Units | |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,243 | 4,243 | - | - | Restricted Stock Units | |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,584 | 0 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 2,057 | 181,382 (0%) | 0% | 106.1 | 218,268 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,362 | 179,108 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,990 | 177,118 (0%) | 0% | 106.1 | 211,159 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,960 | 181,078 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,806 | 179,272 (0%) | 0% | 106.1 | 191,635 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,167 | 183,439 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 11,188 | 11,188 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 28,789 | 28,789 | - | - | Stock Option (Right to Buy) | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,362 | 8,725 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,960 | 3,960 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,167 | 0 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 16,265 | 16,265 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 18,334 | 0 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 16,524 | 1,643,475 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 16,265 | 1,651,750 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 7,865 | 1,643,885 (0%) | 0% | 106.1 | 834,555 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 18,334 | 1,662,219 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 8,865 | 1,653,354 (0%) | 0% | 106.1 | 940,665 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 7,990 | 1,635,485 (0%) | 0% | 106.1 | 847,819 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 35,330 | 35,330 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 90,915 | 90,915 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 16,524 | 33,048 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,850 | 50,101 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,000 | 0 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,839 | 1,839 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,850 | 3,702 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 11,515 | 11,515 | - | - | Stock Option (Right to Buy) | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 4,475 | 4,475 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 484 | 50,671 (0%) | 0% | 106.1 | 51,357 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,000 | 51,155 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 890 | 50,155 (0%) | 0% | 106.1 | 94,438 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,839 | 51,045 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 895 | 49,206 (0%) | 0% | 106.1 | 94,968 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 13 Feb 2025 | 1,266 | 31,211 (0%) | 0% | 106.1 | 134,335 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 13 Feb 2025 | 3,334 | 0 | - | - | Restricted Stock Units | ||
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 13 Feb 2025 | 2,970 | 2,970 | - | - | Restricted Stock Units | ||
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 13 Feb 2025 | 2,776 | 5,552 | - | - | Restricted Stock Units | ||
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 13 Feb 2025 | 13,334 | 13,334 | - | - | Stock Option (Right to Buy) | ||
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 13 Feb 2025 | 5,181 | 5,181 | - | - | Restricted Stock Units | ||
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 13 Feb 2025 | 1,521 | 34,639 (0%) | 0% | 106.1 | 161,393 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 13 Feb 2025 | 3,334 | 36,160 (0%) | 0% | 0 | Common Stock | ||
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 13 Feb 2025 | 1,355 | 32,826 (0%) | 0% | 106.1 | 143,779 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 13 Feb 2025 | 2,970 | 34,181 (0%) | 0% | 0 | Common Stock | ||
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 13 Feb 2025 | 2,776 | 32,477 (0%) | 0% | 0 | Common Stock | ||
| John Bradley Sorenson | EVP, Global Operations | 13 Feb 2025 | 1,273 | 1,273 | - | - | Restricted Stock Units | ||
| John Bradley Sorenson | EVP, Global Operations | 13 Feb 2025 | 1,500 | 0 | - | - | Restricted Stock Units | ||
| John Bradley Sorenson | EVP, Global Operations | 13 Feb 2025 | 2,115 | 27,609 (0%) | 0% | 0 | Common Stock | ||
| John Bradley Sorenson | EVP, Global Operations | 13 Feb 2025 | 965 | 26,644 (0%) | 0% | 106.1 | 102,396 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 13 Feb 2025 | 1,201 | 25,443 (0%) | 0% | 106.3 | 127,678 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 13 Feb 2025 | 1,273 | 26,716 (0%) | 0% | 0 | Common Stock | ||
| John Bradley Sorenson | EVP, Global Operations | 13 Feb 2025 | 581 | 26,135 (0%) | 0% | 106.1 | 61,650 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 13 Feb 2025 | 1,500 | 27,635 (0%) | 0% | 0 | Common Stock | ||
| John Bradley Sorenson | EVP, Global Operations | 13 Feb 2025 | 684 | 26,951 (0%) | 0% | 106.1 | 72,579 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 13 Feb 2025 | 4,239 | 4,239 | - | - | Restricted Stock Units | ||
| John Bradley Sorenson | EVP, Global Operations | 13 Feb 2025 | 10,909 | 10,909 | - | - | Stock Option (Right to Buy) | ||
| John Bradley Sorenson | EVP, Global Operations | 13 Feb 2025 | 2,115 | 4,230 | - | - | Restricted Stock Units | ||
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,172 | 20,935 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,534 | 19,401 (0%) | 0% | 106.1 | 162,773 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,546 | 21,947 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,231 | 20,716 (0%) | 0% | 106.1 | 130,621 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,834 | 23,550 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,315 | 22,235 (0%) | 0% | 106.1 | 139,535 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 8,950 | 8,950 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 23,031 | 23,031 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,172 | 6,346 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,546 | 2,546 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 2,834 | 0 | - | - | Restricted Stock Units | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 667 | 0 | - | - | Restricted Stock Units | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 661 | 1,322 | - | - | Restricted Stock Units | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 636 | 637 | - | - | Restricted Stock Units | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 315 | 3,552 (0%) | 0% | 106.1 | 33,425 | Common Stock |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 661 | 3,867 (0%) | 0% | 0 | Common Stock | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 283 | 4,301 (0%) | 0% | 106.1 | 30,029 | Common Stock |
| Emily Woodworth M. | SVP, Global Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 5,652 | 5,652 | - | - | Restricted Stock Units | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 5,732 | 5,732 | - | - | Stock Option (Right to Buy) | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 636 | 4,188 (0%) | 0% | 0 | Common Stock | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 271 | 3,917 (0%) | 0% | 106.1 | 28,756 | Common Stock |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 667 | 4,584 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.10 per share. | 13 Feb 2025 | 30 | 1,667 (0%) | 0% | 106.1 | 3,183 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 85 | 1,697 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 38 | 1,612 (0%) | 0% | 106.1 | 4,032 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 100 | 0 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 85 | 85 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 106 | 212 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 188 | 188 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,000 | 0 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 990 | 990 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,123 | 2,248 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 6,061 | 6,061 | - | - | Stock Option (Right to Buy) | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 2,355 | 2,355 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 36 | 1,731 (0%) | 0% | 106.1 | 3,820 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 100 | 1,767 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,123 | 13,702 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 330 | 13,372 (0%) | 0% | 106.1 | 35,016 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 990 | 14,362 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 291 | 14,071 (0%) | 0% | 106.1 | 30,878 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 1,000 | 15,071 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 294 | 14,777 (0%) | 0% | 106.1 | 31,196 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 106 | 1,650 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 3,654 | 245,105 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 1,767 | 243,338 (0%) | 0% | 105.8 | 186,896 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 3,654 | 10,963 | - | - | Restricted Stock Units | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 3,462 | 176,325 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 1,579 | 174,746 (0%) | 0% | 105.8 | 167,011 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 3,462 | 10,386 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 6,626 | 1,626,951 (0%) | 0% | 105.8 | 700,832 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 13,704 | 41,112 | - | - | Restricted Stock Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 13,704 | 1,633,577 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,442 | 4,328 | - | - | Restricted Stock Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 424 | 48,251 (0%) | 0% | 105.8 | 44,846 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 1,442 | 48,675 (0%) | 0% | 0 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 12 Feb 2025 | 2,115 | 6,347 | - | - | Restricted Stock Units | ||
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 12 Feb 2025 | 868 | 29,701 (0%) | 0% | 105.8 | 91,808 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 12 Feb 2025 | 2,115 | 30,569 (0%) | 0% | 0 | Common Stock | ||
| John Bradley Sorenson | EVP, Global Operations | 12 Feb 2025 | 530 | 25,494 (0%) | 0% | 105.8 | 56,058 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 12 Feb 2025 | 1,731 | 5,193 | - | - | Restricted Stock Units | ||
| John Bradley Sorenson | EVP, Global Operations | 12 Feb 2025 | 1,731 | 26,024 (0%) | 0% | 0 | Common Stock | ||
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 950 | 17,763 (0%) | 0% | 105.8 | 100,482 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 2,692 | 8,078 | - | - | Restricted Stock Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 2,692 | 18,713 (0%) | 0% | 0 | Common Stock | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 231 | 3,206 (0%) | 0% | 105.8 | 24,433 | Common Stock |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 480 | 1,443 | - | - | Restricted Stock Units | |
| Emily Woodworth M. | SVP, Global Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 480 | 3,437 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 65 | 196 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 961 | 2,885 | - | - | Restricted Stock Units | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.78 per share. | 12 Feb 2025 | 23 | 1,544 (0%) | 0% | 105.8 | 2,433 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 65 | 1,567 (0%) | 0% | 0 | Common Stock | |
| Miriam O'Sullivan | SVP, Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 338 | 12,579 (0%) | 0% | 105.8 | 35,750 | Common Stock |
| Miriam O'Sullivan | SVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 961 | 12,917 (0%) | 0% | 0 | Common Stock | |
| Edward J. Ludwig | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 3,000 | 36,398 (0%) | 0% | 0 | Common Stock | |
| Edward J. Ludwig | Director | Sale of securities on an exchange or to another person at price $ 105.48 per share. | 11 Feb 2025 | 12,000 | 24,398 (0%) | 0% | 105.5 | 1,265,815 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Sale of securities on an exchange or to another person at price $ 105.07 per share. | 11 Feb 2025 | 15,087 | 241,451 (0%) | 0% | 105.1 | 1,585,135 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 11 Feb 2025 | 15,087 | 256,538 (0%) | 0% | 16.3 | 246,069 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 15,087 | 0 | - | - | Stock Option (Right to Buy) | |
| Daniel J. Brennan | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 33,944 | 257,865 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 16,414 | 241,451 (0%) | 0% | 106.0 | 1,739,556 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 130,118 | 1,682,788 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 62,915 | 1,619,873 (0%) | 0% | 106.0 | 6,667,732 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 6,350 | 47,233 (0%) | 0% | 106.0 | 672,973 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 14,708 | 53,583 (0%) | 0% | 0 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 11 Feb 2025 | 10,738 | 41,476 (0%) | 0% | 106.0 | 1,138,013 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 11 Feb 2025 | 13,022 | 28,454 (0%) | 0% | 105.1 | 1,368,073 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 11 Feb 2025 | 23,760 | 52,214 (0%) | 0% | 0 | Common Stock | ||
| John Bradley Sorenson | EVP, Global Operations | 11 Feb 2025 | 6,389 | 24,293 (0%) | 0% | 105.1 | 671,249 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 11 Feb 2025 | 10,182 | 36,631 (0%) | 0% | 0 | Common Stock | ||
| John Bradley Sorenson | EVP, Global Operations | 11 Feb 2025 | 3,793 | 32,838 (0%) | 0% | 106.0 | 401,982 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 11 Feb 2025 | 2,156 | 30,682 (0%) | 0% | 0 | Common Stock | ||
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 20,366 | 25,868 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 11 Feb 2025 | 9,847 | 16,021 (0%) | 0% | 106.0 | 1,043,585 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | 07 Feb 2025 | 6,528 | 26,449 (0%) | 0% | 105.0 | 685,244 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 101.45 per share. | 03 Feb 2025 | 8,508 | 14,307 (0%) | 0% | 101.5 | 863,169 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 03 Feb 2025 | 1,009 | 22,815 (0%) | 0% | 17.3 | 17,415 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.71 per share. | 03 Feb 2025 | 3,176 | 21,806 (0%) | 0% | 22.7 | 72,127 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.55 per share. | 03 Feb 2025 | 6,176 | 18,630 (0%) | 0% | 24.6 | 151,621 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.09 per share. | 03 Feb 2025 | 6,952 | 12,454 (0%) | 0% | 27.1 | 188,330 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 3,176 | 9,530 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 6,176 | 18,527 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 1,009 | 3,027 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 6,952 | 20,856 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 102.14 per share. | 03 Feb 2025 | 8,805 | 5,502 (0%) | 0% | 102.1 | 899,338 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 14,901 | 238,822 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Brennan | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 14,901 | 0 | - | - | Performance Share Units | |
| Daniel J. Brennan | EVP and CFO | Sale of securities on an exchange or to another person at price $ 89.86 per share. | 01 Jan 2025 | 9,689 | 223,921 (0%) | 0% | 89.9 | 870,636 | Common Stock |
| Daniel J. Brennan | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 5,212 | 233,610 (0%) | 0% | 89.3 | 465,536 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 13,907 | 162,025 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 6,425 | 155,600 (0%) | 0% | 89.3 | 573,881 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 13,907 | 0 | - | - | Performance Share Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 57,121 | 0 | - | - | Performance Share Units | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 57,121 | 1,578,326 (0%) | 0% | 0 | Common Stock | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 25,656 | 1,552,670 (0%) | 0% | 89.3 | 2,291,594 | Common Stock |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 6,456 | 0 | - | - | Performance Share Units | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 6,456 | 40,866 (0%) | 0% | 0 | Common Stock | |
| Vance R. Brown | SVP, GC and Corp. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 1,991 | 38,875 (0%) | 0% | 89.3 | 177,836 | Common Stock |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 01 Jan 2025 | 10,430 | 0 | - | - | Performance Share Units | ||
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 01 Jan 2025 | 10,430 | 38,884 (0%) | 0% | 0 | Common Stock | ||
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 01 Jan 2025 | 3,278 | 35,606 (0%) | 0% | 89.3 | 292,791 | Common Stock | |
| Jeffrey B. Mirviss | EVP&Pres, Periph Intervent | 01 Jan 2025 | 7,152 | 28,454 (0%) | 0% | 89.9 | 642,658 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 01 Jan 2025 | 2,127 | 39,438 (0%) | 0% | 89.3 | 189,984 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 01 Jan 2025 | 4,119 | 35,319 (0%) | 0% | 90.0 | 370,792 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 01 Jan 2025 | 2,342 | 32,977 (0%) | 0% | 89.9 | 210,449 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 01 Jan 2025 | 4,469 | 0 | - | - | Performance Share Units | ||
| John Bradley Sorenson | EVP, Global Operations | 01 Jan 2025 | 4,469 | 41,565 (0%) | 0% | 0 | Common Stock | ||
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 4,416 | 5,502 (0%) | 0% | 89.3 | 394,437 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 8,940 | 0 | - | - | Performance Share Units | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 8,940 | 9,918 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Purchase of securities on an exchange or from another person at price $ 90.30 per share. | 03 Dec 2024 | 50 | 148,168 (0%) | 0% | 90.3 | 4,515 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 03 Dec 2024 | 14,447 | 172,863 (0%) | 0% | 106.0 | 1,531,093 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2024 | 31,680 | 187,310 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 89.95 per share. | 03 Dec 2024 | 20 | 148,148 (0%) | 0% | 90.0 | 1,799 | Common Stock |
| Wendy Carruthers | EVP, Human Resources | 02 Dec 2024 | 3,066 | 35,094 (0%) | 0% | 17.3 | 52,919 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 02 Dec 2024 | 1,197 | 13,183 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 02 Dec 2024 | 3,066 | 0 | - | - | Stock Option (Right to Buy) | ||
| Wendy Carruthers | EVP, Human Resources | 02 Dec 2024 | 6,983 | 29,308 (0%) | 0% | 90.8 | 633,917 | Common Stock | |
| Wendy Carruthers | EVP, Human Resources | 02 Dec 2024 | 1,197 | 36,291 (0%) | 0% | 24.5 | 29,386 | Common Stock | |
| Emily Woodworth | SVP, Global Controller and CAO | 27 Nov 2024 | 1,336 | 2,957 (0%) | 0% | 90.6 | 121,105 | Common Stock | |
| F. Michael Mahoney | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Nov 2024 | 7,800 | 201,478 (0%) | 0% | 0 | Common Stock | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 3,177 | 12,706 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Sale of securities on an exchange or to another person at price $ 89.27 per share. | 25 Nov 2024 | 14,010 | 978 (0%) | 0% | 89.3 | 1,250,664 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 1,009 | 4,036 | - | - | Stock Option (Right to Buy) | |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.71 per share. | 25 Nov 2024 | 3,177 | 13,979 (0%) | 0% | 22.7 | 72,150 | Common Stock |
| Arthur C. Butcher | EVP& Grp Pres, MedSurg & APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 25 Nov 2024 | 1,009 | 14,988 (0%) | 0% | 17.3 | 17,415 | Common Stock |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 1,113 | 159,354 (0%) | 0% | 0 | Common Stock | |
| Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 11,236 | 148,118 (0%) | 0% | 0 | Common Stock | |
| Edward J. Ludwig | Director | Sale of securities on an exchange or to another person at price $ 91.63 per share. | 21 Nov 2024 | 4,877 | 39,398 (0%) | 0% | 91.6 | 446,902 | Common Stock |
| John Bradley Sorenson | EVP, Global Operations | 12 Nov 2024 | 2,610 | 37,096 (0%) | 0% | 0 | Common Stock | ||
| John Bradley Sorenson | EVP, Global Operations | 08 Nov 2024 | 30,580 | 39,706 (0%) | 0% | 87.7 | 2,680,572 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 08 Nov 2024 | 17,362 | 70,286 (0%) | 0% | 24.5 | 426,237 | Common Stock | |
| John Bradley Sorenson | EVP, Global Operations | 08 Nov 2024 | 17,362 | 0 | - | - | Stock Option (Right to Buy) | ||
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 85.17 per share. | 05 Nov 2024 | 2,596 | 1,681,387 (0%) | 0% | 85.2 | 221,108 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 84.74 per share. | 05 Nov 2024 | 160,182 | 1,521,205 (0%) | 0% | 84.7 | 13,573,743 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2024 | 56,211 | 168,635 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2024 | 55,676 | 0 | - | - | Stock Option (Right to Buy) | |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 05 Nov 2024 | 56,211 | 1,628,307 (0%) | 0% | 17.3 | 970,202 | Common Stock |
| Michael F. Mahoney | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 05 Nov 2024 | 55,676 | 1,683,983 (0%) | 0% | 16.3 | 908,076 | Common Stock |